PL1711507T3 - Forma krystaliczna monosodowej soli kwasu rizedronowego - Google Patents
Forma krystaliczna monosodowej soli kwasu rizedronowegoInfo
- Publication number
- PL1711507T3 PL1711507T3 PL05700509T PL05700509T PL1711507T3 PL 1711507 T3 PL1711507 T3 PL 1711507T3 PL 05700509 T PL05700509 T PL 05700509T PL 05700509 T PL05700509 T PL 05700509T PL 1711507 T3 PL1711507 T3 PL 1711507T3
- Authority
- PL
- Poland
- Prior art keywords
- crystalline form
- risedronate monosodium
- risedronate
- monosodium
- hydroxyethylidene
- Prior art date
Links
- DRFDPXKCEWYIAW-UHFFFAOYSA-M Risedronate sodium Chemical compound [Na+].OP(=O)(O)C(P(O)([O-])=O)(O)CC1=CC=CN=C1 DRFDPXKCEWYIAW-UHFFFAOYSA-M 0.000 title 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 abstract 1
- 238000002441 X-ray diffraction Methods 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Cephalosporin Compounds (AREA)
- Steroid Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Developing Agents For Electrophotography (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ20040199A CZ298639B6 (cs) | 2004-02-05 | 2004-02-05 | Krystalická forma risedronátu monosodného |
| PCT/CZ2005/000012 WO2005075487A1 (en) | 2004-02-05 | 2005-02-04 | Crystalline form of risedronate monosodium |
| EP05700509A EP1711507B1 (en) | 2004-02-05 | 2005-02-04 | Crystalline form of risedronate monosodium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1711507T3 true PL1711507T3 (pl) | 2009-06-30 |
Family
ID=34832121
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05700509T PL1711507T3 (pl) | 2004-02-05 | 2005-02-04 | Forma krystaliczna monosodowej soli kwasu rizedronowego |
| PL380526A PL380526A1 (pl) | 2004-02-05 | 2005-02-04 | Odmiana krystaliczna rizedronianu monosodowego |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL380526A PL380526A1 (pl) | 2004-02-05 | 2005-02-04 | Odmiana krystaliczna rizedronianu monosodowego |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1711507B1 (pl) |
| AT (1) | ATE416182T1 (pl) |
| CZ (1) | CZ298639B6 (pl) |
| DE (1) | DE602005011401D1 (pl) |
| EA (1) | EA008494B1 (pl) |
| PL (2) | PL1711507T3 (pl) |
| UA (1) | UA85218C2 (pl) |
| WO (1) | WO2005075487A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK50782006A3 (sk) † | 2004-02-26 | 2007-03-01 | Zentiva, A. S. | Amorfné formy risedronátu monosodného |
| WO2007042048A2 (en) * | 2005-10-11 | 2007-04-19 | Sandoz A/S | Method for preparing crystalline sodium risedronate |
| JP2009536639A (ja) | 2006-05-11 | 2009-10-15 | アイエヌディー−スイフト ラボラトリーズ リミテッド | 純リセドロン酸または塩を調製するための方法 |
| DE102007030370A1 (de) | 2007-06-29 | 2009-01-02 | Ratiopharm Gmbh | Essigsäure-Solvate von Risedronat, Polymorph hiervon, deren Herstellung und Verwendung sowie pharmazeutische Zusammensetzung, enthaltend diese |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2728805B1 (fr) * | 1994-12-29 | 1997-03-28 | Total Raffinage Distribution | Procede et dispositif pour le strippage de solides fluidises et utilisation dans un procede de craquage a l'etat fluide |
| PE20011061A1 (es) * | 2000-02-01 | 2001-11-20 | Procter & Gamble | Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato |
| WO2003086355A1 (en) * | 2002-04-11 | 2003-10-23 | Teva Pharmaceutical Indudstries, Ltd. | Novel polymorphs and pseudopolymorphs of risedronate sodium |
-
2004
- 2004-02-05 CZ CZ20040199A patent/CZ298639B6/cs not_active IP Right Cessation
-
2005
- 2005-02-04 PL PL05700509T patent/PL1711507T3/pl unknown
- 2005-02-04 DE DE602005011401T patent/DE602005011401D1/de not_active Expired - Fee Related
- 2005-02-04 WO PCT/CZ2005/000012 patent/WO2005075487A1/en not_active Ceased
- 2005-02-04 EP EP05700509A patent/EP1711507B1/en not_active Expired - Lifetime
- 2005-02-04 EA EA200601366A patent/EA008494B1/ru not_active IP Right Cessation
- 2005-02-04 UA UAA200609599A patent/UA85218C2/ru unknown
- 2005-02-04 PL PL380526A patent/PL380526A1/pl not_active IP Right Cessation
- 2005-02-04 AT AT05700509T patent/ATE416182T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| UA85218C2 (en) | 2009-01-12 |
| ATE416182T1 (de) | 2008-12-15 |
| EP1711507B1 (en) | 2008-12-03 |
| PL380526A1 (pl) | 2007-02-19 |
| EA008494B1 (ru) | 2007-06-29 |
| CZ298639B6 (cs) | 2007-12-05 |
| DE602005011401D1 (de) | 2009-01-15 |
| EA200601366A1 (ru) | 2006-12-29 |
| CZ2004199A3 (cs) | 2005-09-14 |
| WO2005075487A1 (en) | 2005-08-18 |
| EP1711507A1 (en) | 2006-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200205090B (en) | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate. | |
| IL162734A0 (en) | Phosphorus-containing compounds & uses thereof | |
| TW200716624A (en) | Compounds for modulating TRPV3 function | |
| EA200702217A1 (ru) | Безводные кристаллические формы n-[1-(2-этоксиэтил)-5-(n-этил-n-метиламино)-7-(4-метилпиридин-2-иламино)-1h-пиразоло[4,3-d]пиримидин-3-карбонил]метансульфонамида | |
| AU2003300898A1 (en) | Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators | |
| UA93351C2 (uk) | Похідні фталазіну як інгібітори parp | |
| IL172047A0 (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
| ATE433988T1 (de) | Phosphoramidatderivate | |
| TW200626068A (en) | Active compounds for seed treatment | |
| IS7453A (is) | Trópan afleiður sem CCR5 stillar | |
| IL172825A (en) | Preparation of 1,3-diphenylprop-2-en-1-one derivatives | |
| MX2008008298A (es) | Sal de sulfato de hidrogeno novedosa. | |
| ATE516291T1 (de) | Thenopyrimidin-verbindungen mit fungizider aktivität | |
| PL1711507T3 (pl) | Forma krystaliczna monosodowej soli kwasu rizedronowego | |
| UA83900C2 (en) | Amorphous forms of risedronate monosodium | |
| WO2007023342A3 (en) | Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof | |
| MX2010002523A (es) | Compuestos de piperidinilamino-tieno[2,3-d] pirimidina para tratar la fibrosis. | |
| TW200724168A (en) | Pharmaceutical compositions | |
| PL1845780T3 (pl) | Zastosowanie pochodnych metylofenidatu | |
| ZA200301297B (en) | Control of encrustations of phosphate-containing double salts. | |
| MXPA05009243A (es) | N-aril-2-oxazolidinona-5-carboxamidas y sus derivados. | |
| SK51032005A3 (sk) | Trojsodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej | |
| MY144456A (en) | Pesticidal agents on the basis of 1-aryl-aminopyrrol | |
| UA84244C2 (ru) | Кристаллическая двойная соль аквааминоортофосфата меди (ii)-кадмия и способ ее получения | |
| UA6377U (en) | Quaternary triphenylphosphonium salt |